178 related articles for article (PubMed ID: 25929909)
1. Radiotherapy- and chemotherapy-induced myelodysplasia syndrome: a nationwide population-based nested case-control study.
Sun LM; Lin CL; Lin MC; Liang JA; Kao CH
Medicine (Baltimore); 2015 May; 94(17):e737. PubMed ID: 25929909
[TBL] [Abstract][Full Text] [Related]
2. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract][Full Text] [Related]
3. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
[TBL] [Abstract][Full Text] [Related]
4. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
Kaplan H; Malmgren J; De Roos AJ
Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
[TBL] [Abstract][Full Text] [Related]
6. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma Survivors.
Sanford NN; Miao R; Wang H; Goldberg S; Jacobson A; Brunner AM; Cote GM; Yock TI; Ebb DH; Chen YB; Jee KW; Hornicek F; DeLaney TF; Choy E; Chen YL
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):52-61. PubMed ID: 30165126
[TBL] [Abstract][Full Text] [Related]
8. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
9. Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation.
Mukherjee S; Reddy CA; Ciezki JP; Abdel-Wahab M; Tiu RV; Copelan E; Advani AA; Saunthararajah Y; Paulic K; Hobson S; Maciejewski JP; Bolwell BJ; Kalaycio M; Dreicer R; Klein EA; Sekeres MA
J Natl Cancer Inst; 2014 Mar; 106(3):djt462. PubMed ID: 24577815
[TBL] [Abstract][Full Text] [Related]
10. Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany.
Kaatsch P; Reinisch I; Spix C; Berthold F; Janka-Schaub G; Mergenthaler A; Michaelis J; Blettner M
Cancer Causes Control; 2009 Aug; 20(6):965-80. PubMed ID: 19263232
[TBL] [Abstract][Full Text] [Related]
11. Secondary myelodysplastic syndromes and leukaemias.
Levine EG; Bloomfield CD
Clin Haematol; 1986 Nov; 15(4):1037-80. PubMed ID: 3552347
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related myelodysplastic syndromes, or are they?
Abou Zahr A; Kavi AM; Mukherjee S; Zeidan AM
Blood Rev; 2017 May; 31(3):119-128. PubMed ID: 27923516
[TBL] [Abstract][Full Text] [Related]
14. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
Freedman RA; Seisler DK; Foster JC; Sloan JA; Lafky JM; Kimmick GG; Hurria A; Cohen HJ; Winer EP; Hudis CA; Partridge AH; Carey LA; Jatoi A; Klepin HD; Citron M; Berry DA; Shulman LN; Buzdar AU; Suman VJ; Muss HB
Breast Cancer Res Treat; 2017 Jan; 161(2):363-373. PubMed ID: 27866278
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).
Yarosh R; Roesler MA; Murray T; Cioc A; Hirsch B; Nguyen P; Warlick E; Poynter JN
Cancer Causes Control; 2021 Mar; 32(3):241-250. PubMed ID: 33392905
[TBL] [Abstract][Full Text] [Related]
16. Increasing risks of ischemic stroke in oral cancer patients treated with radiotherapy or chemotherapy: a nationwide cohort study.
Wu YT; Chen CY; Lai WT; Kuo CC; Huang YB
Int J Neurosci; 2015; 125(11):808-16. PubMed ID: 25233149
[TBL] [Abstract][Full Text] [Related]
17. Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience.
Smith RE
Clin Breast Cancer; 2003 Oct; 4(4):273-9. PubMed ID: 14651772
[TBL] [Abstract][Full Text] [Related]
18. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors.
Kaplan HG; Malmgren JA; Li CI; Calip GS
Breast Cancer Res Treat; 2013 Dec; 142(3):629-36. PubMed ID: 24265034
[TBL] [Abstract][Full Text] [Related]
19. Relative risk of myelodysplastic syndromes in patients with autoimmune disorders in the General Practice Research Database.
Wilson AB; Neogi T; Prout M; Jick S
Cancer Epidemiol; 2014 Oct; 38(5):544-9. PubMed ID: 25189344
[TBL] [Abstract][Full Text] [Related]
20. Incidence of myelodysplastic syndromes in patients receiving concurrent myelosuppressive chemotherapy and pegfilgrastim.
Covert WM; Murillo JR; Cox JE
J Oncol Pharm Pract; 2011 Dec; 17(4):366-71. PubMed ID: 20876080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
